Get the latest news and blog posts from APCI, including press releases and articles about advocacy actions, industry happenings, clinical pharmacy information, independent pharmacy operations, and much more.
APCI challenges claims that Medicaid payment parity would cost $1 billion in New York, arguing the true figure is far lower and urging transparency around the state’s analysis.
A new study reveals how PBMs and Part D plans increase drug costs for seniors through misaligned incentives and fees, while outlining a path to save patients billions.
APCI backs the DOJ’s move to block UnitedHealth’s acquisition of Change Healthcare, citing risks to competition, patient choice, and prescription drug pricing.
After an FTC deadlock stalls a probe into PBM practices, APCI vows to keep pushing for transparency and accountability in prescription drug pricing.
APCI warns Congress is missing a key chance to curb PBM spread pricing and reform Medicaid managed care, leaving taxpayers, patients, and community pharmacies to bear the cost.
APCI urges Governor Hochul to sign critical PBM reform legislation that strengthens patient choice, increases transparency, and protects New York’s community pharmacies.